Carriage Services (CSV) Q2 2026 earnings review
Pricing Power Masks a Broad Volume Slump
Carriage Services continues to battle a national mortality slump by leaning heavily on aggressive pricing and preneed insurance sales. Despite a 4.0% drop in funeral volumes and a 14.0% collapse in cemetery properties sold, total revenue edged up 0.8% YoY. The real victory lies in cost execution: management expanded Adjusted EBITDA margins by 70 basis points to 32.3%. However, the decision to cut full-year top-line guidance—while maintaining cash flow targets by slashing CapEx—reveals that the volume environment is tougher than initially projected.
🐂 Bull Case
Adjusted EBITDA grew 3.1% to $33.3 million. By reducing overhead to 11.8% of revenue (down from 12.2%), the company effectively neutralized the profitability drag caused by fewer services.
Insurance-funded preneed funeral contracts jumped 21.1%, driving a 14.0% surge in high-margin financial revenue. The strategic pivot toward proactive pipeline building is working.
🐻 Bear Case
Lower-than-anticipated mortality trends forced a $5 million cut to the FY26 revenue outlook. If death rates remain suppressed, Carriage will eventually hit a ceiling on price elasticity.
Preneed interment rights sold plunged 14.0% YoY. A 17.3% price hike shielded the revenue, but starving unit velocity puts long-term market share at risk.
⚖️ Verdict: ⚪
Neutral. The operational discipline is exceptional, but the macro environment is fighting them. They are pulling every financial and pricing lever available, but a business reliant on volume can only hike prices for so long before consumers trade down.
Key Themes
Aggressive Price Realization
Accelerating. Carriage is entirely dependent on its pricing power right now. Consolidated average revenue per funeral contract grew 4.7% to $6,048, while cemetery average price per preneed interment right skyrocketed 17.3% to $6,884. This aggressive realization offset severe volume declines across both segments.
Preneed Insurance Sales execution
Accelerating. Financial revenue jumped 14.0% to $9.3M, supercharged by a 21.1% increase in insurance-funded preneed funeral contracts. This validates the proactive sales model implemented with partner Precoa over the last two years, proving that Carriage can organically generate future backlogs even when walk-in mortality drops.
Disciplined Overhead Optimization
Stable. Total overhead came in at 11.8% of revenue, down from 12.2% a year ago. Following major post-2024 restructurings, field-level and corporate cost controls have solidified, directly contributing to the 70 bps expansion in Adjusted EBITDA margins (32.3%).
Macro Headwind: The Mortality Slump
Decelerating. Management explicitly cited 'lower national mortality trends' as the primary reason for a 3.5% drop in at-need volumes and a 4.0% drop in overall funeral contracts. With the FY26 revenue guide subsequently lowered, the expected demographic tailwind of aging Baby Boomers appears delayed or masked by post-pandemic pull-forward normalization.
Cemetery Elasticity Reaching Limits
Reversing. The cemetery segment saw a 14.0% decline in preneed property units sold. In prior quarters (like Q4 25), units grew at 10%+. While the 17.3% price hike rescued revenue, bleeding out 14% of unit volume is a massive red flag indicating that high-end inventory is pricing out core consumers.
Engineering the Free Cash Flow Target
Adjusted Free Cash Flow dropped significantly in Q2 to $2.6M from $6.9M a year ago. Yet, management maintained the full-year FCF guidance of $40-$50M. How? By simultaneously cutting the FY26 CapEx budget by $5 million. This contradicts the positive 'growth mode' narrative, suggesting they are sacrificing infrastructure investment to protect a headline metric.
Technology and Sales Automation Ramp
Carriage's 5.0% increase in cemetery preneed sales production is directly supported by its recent tech rollout, namely the 'Sales Edge 2.0' CRM and 'Titan' AI-powered sales agent. The ability to maintain positive sales production dollars while unit volumes drop implies these tools are successfully targeting higher-net-worth leads.
Other KPIs
Accelerating. Up 14.0% YoY. This is the highest margin segment of the business (typically generating ~93% EBITDA margins). Its continued outperformance provides an outsized boost to the bottom line, acting as a crucial shock absorber against the heavy fixed costs of the funeral segment.
Decelerating sharply from $6.90 million in 25Q2. The drop was largely driven by a heavy step-up in capital expenditures ($5.3M vs $2.8M last year) and working capital timing, resulting in a tighter liquidity profile for the quarter.
Guidance
Decelerating. Lowered from the previous $440-$450 million range. The $440M midpoint implies roughly 5.4% YoY growth from FY25's $417.4M. Management attributes the haircut to the national mortality slump and revised timing on expected M&A closings.
Stable. Unchanged despite the revenue cut. The midpoint of $137.5M implies a 5.2% growth over FY25 ($130.7M). Reaffirming this metric signals extreme confidence in ongoing cost containment and price realization.
Stable. Unchanged. The midpoint implies a strong 7.8% growth against FY25's $3.20. Given stable debt levels and the lack of a buyback program, this EPS growth relies entirely on operating leverage.
Decelerating. Lowered from the original guide of $25-$30 million. This $5M reduction perfectly matches the shortfall required to keep their Adjusted Free Cash Flow target intact.
Key Questions
Cemetery Volume Elasticity
Preneed interment rights sold dropped 14% this quarter against a 17% price hike. At what point does pricing pressure permanently damage your pipeline and market share?
CapEx Reductions
You lowered the FY26 CapEx guide by $5 million. Are you delaying critical growth infrastructure or the Trinity ERP rollout to artificially protect the $40-$50M FCF guidance?
M&A Timeline Slippage
The guidance revision cited 'revised timing of expected acquisitions.' Are deal multiples remaining stubbornly high, or are sellers walking away from the table due to the mortality slump?
Mortality Normalization
Given the 3.5% drop in at-need volumes, does your internal modeling suggest we have found the absolute trough in post-COVID pull-forward effects, or could 2027 see further base volume deterioration?